WHO WE ARE
Revolutioniser of personalised medicine
GO-Dx Singapore operates a medical diagnostics and diagnostics technology business in Singapore (Business) focused on pioneering biomedical technology in rapid diagnostics, leveraging artificial intelligence and data analytics to empower individuals with personalised and effective healthcare products and solutions.
The Business is focused on providing diagnostic testing and analysis services and the sale and distribution of nutraceutical products.
Our purpose
To deliver cutting-edge and proprietary technology in rapid diagnostics, leveraging artificial intelligence and data analytics to empower individuals with personalised and effective healthcare solutions, ultimately promoting health and wellness for all of humanity.
Our Mission
To transform the field of diagnostics and wellness by building an ecosystem that leverages the power of molecular pathology, microbiome immunology, health data, and artificial intelligence. We envision a future where every individual has access to personalised and accurate health information, enabling them to make informed decisions about their health and wellness. Our goal is to develop innovative solutions that not only diagnose but also prevent diseases, providing better health outcomes for all of humanity.
How we do it
Through collaboration with experts in these fields, we strive to push the boundaries of what is possible, driving progress and advancements that benefit society as a whole. We are committed to providing exceptional service to our clients and partners, utilizing our expertise and technology to deliver accurate and timely diagnostic information. At GO-Dx, we are dedicated to improving the health and well-being of individuals and communities worldwide, and we are proud to be at the forefront of this important work.
Products and Services
The Products include the products which the Company has rights to distribute in various Asian territories including
• “G’Nest Deluxe” and “G’Nest Premium” products manufactured and supplied by FEGO Biotech Pte Ltd;
and
• “C’Neuros” product manufactured and supplied by NGF Bioenterprise Pte Ltd (Products Range).
The Services include diagnostic testing and analysis services including:
• RNA mining/mapping & analytics platform
• Neurological and immunological precision medicine via proprietary genetic and epigenetic screening
Plus services currently in research and development phase, and planned for future commercialisation:
• miRNA-based early screening tests for various cancers and diagnostic platforms
• Chronic/infectious disease prediction via proprietary DNA profiling and fluorescence in situ hybridisation (FISH) platforms
• Liquid biopsy based diagnostics for cancers using NGS technology
• Al-enabled platform (Services Range)
Meet our Management Team
Our success lies in years of experience in biotechnology, biopharmaceutical, healthcare, venture capital industry.
Dr Lim Kah Meng
Chief Executive Officer / Chief Scientific Officer
Experienced scientist in the biotechnology and biopharmaceutical industry
Started his career as a Research Scientist in A*Star and as a Professor in NTU before venturing as an entrepreneur and advisor to several biotech companies
Currently serving as Independent Director in a SGX listed company and Board director in several other biotech companies
Holds Ph.D. in Biomedicine from National University of Singapore
Scientific Teams
Dr Lim Kah Meng
Chief Executive Officer / Chief Scientific Officer
Experienced scientist in the biotechnology and biopharmaceutical industry
Started his career as a Research Scientist in A*Star and as a Professor in NTU before venturing as an entrepreneur and advisor to several biotech companies
Currently serving as Independent Director in a SGX listed company and Board director in several other biotech companies
Holds Ph.D. in Biomedicine from National University of Singapore
Dr. Leong Wai Fook
CTO Designate
Senior research fellow in Singapore Immunology Network, A-STAR
Council member in the Singapore Society for Microbiology and Biotechnology
Ph.D. in Microbiology (Virology) at the National University of Singapore
Dr. Rose
Seconded Lead Scientist
Versatile and innovative professional with more than 10 years of experience in stem cells, tissue engineering and material science technology within multiple research environments. A creative, proactive, analytical and result driven scientist with exceptional initiative and productive creativity leading to enhancement of organizational initiatives and thus successful delivery of results.
Operation (Market/Investments) Teams
Nikko
Business Development
Colby J Colasanto
Investment Communications
Gow Hui Yian
Market Development
Highly experienced Chartered Accountant with over 20 years in corporate finance and leadership. Global Business Developer in Healthcare and Wellness.
Operation (Corporate) Teams
Irene
Financial Controller
Experienced accountant with over 20 years in accountancy and finance
Novanne Seah
Chief Admin and Board Coordinator
Serial Entrepreneur and Investor
Successful product development and commercialisation for multiple food/wellness products
Proven ability to manage the organisation’s budget, achieving 50% cost savings through strategic vendor negotiations and process improvements
Implemented a risk management strategy that reduced operational risks and improved overall compliance with regulations
Executed a successful IPO and on-going IPO
Meet our Board of Advisors
Our advisors, including geneticists and virologists, are renowned leaders in the scientific community with extensive years of experience.
Prof. Moshe Szyf
Advisor
Professor at department of Pharmacology and Therapeutics, McGill University
GlaxoSmithKline-CIHR chair in Pharmacology, McGill University
Founding co-director of the Sackler Institute for Epigenetics and Psychobiology, McGill University
Founder of Montreal EpiTerapia Inc, and HKG Epitherapeutics
Ph.D. in Genetics, Hebrew University
Post doctoral on DNA Methylation, Harvard Medical School
Dr. Tung Dang Xuan Tran
Advisor
Dr. Tung Dang Xuan Tran, MD, PhD Notable Associations: Pham Ngoc Thach Medical University (HCM City, Vietnam), Taipei Medical University (Taiwan), Harvard Medical University (USA) Achievements & Awards:
Dr. Tran is at the forefront of stem cell therapies, pioneering disease treatment with mesenchymal stem cell technology. His significant contributions include numerous clinical trials and the Ministry of Health’s licensing of routine osteoarthritis treatment with stem cells in 2016.
Dr. Tran’s research has been published in prestigious scientific journals, and he leads the exceptional Stem Cell Unit at Van Hanh Hospital, which has been recognized for its excellence and was assigned by the State of Vietnam.
Prof. Dr. Rupert Handgretinger
Advisor
Senior Professor, Children’s University Hospital Tübingen, Germany
Consultant, Abu Dhabi Stem Cell Center , Abu Dhabi, UAE
George and Jennifer Yeo Endowed Chair in Pediatric Oncology, Yong Loo Lin School of Medicine,
National University of Singapore
Dr. Kampon Sriwatanakul
Advisor
Dr. Kampon Sriwatanakul is an internationally recognized pioneer of Celltherapy who received M.D. degree and Ph.D. degree from Mahidol University where he had an academic career for more than 35 years. He also received training in Clinical
Pharmacology from University of Leicester, U.K. and University of Rochester, N.Y., USA.
Dr. Kampon Sriwatanakul has spearheaded a number of important research and
development activities related to Stem Cell Technology in Thailand, including setting up of Cord Blood and Tooth cell banking. He has received several awards for research and innovation from British and American academic institutions and the National Innovation Agency of Thailand.
Prof. Ralph Martins
Advisor
Professor Ralph Martins has dedicated over 40 years to Alzheimer’s Disease research.
He is well-known and highly respected internationally as a prominent researcher in the field.
His insight into this devastating disease has led to a number of ground-breaking discoveries. Professor Martins and his team have been at the forefront globally in developing non-invasive and cost-effective early diagnostics for pre-clinical Alzheimer’s disease.
Dr. Chong Chun Wie
Advisor
Dr. Chong (BSc (HONS) Biochemistry, PhD (Microbial Ecology) is an Associate Professor and the Deputy Head of School (Research) at the School of Pharmacy, Monash University Malaysia. Dr. Chong is an experienced researcher in microbial ecology, gut microbiome science and digital health. As a leader of microbiome science in Malaysia, he participated actively in public talks and forums on gut health topics related to disease, diet and lifestyle. With over a decade of interdisciplinary expertise, his work bridges microbiology, public health, and technology to address global challenges such as diabetes prevention, antimicrobial resistance (AMR), and neurodegenerative disorders. His current research interest includes understanding the role of the gut-brain axis in neurological disorders, the interplay between diet, gut microbiome and host metabolism, and the impact of antibiotics on the gut microbiome.
Dr. Scott Lim
Advisor
Dr. Scott Lim is an experienced physician who, in 2016, expanded his focus from conventional medicine to the fields of biological and precision medicine.
In his practice, he successfully combines the principles of these two approaches to offer comprehensive and individually tailored treatment. He considers all factors that influence your health—from nutrition and lifestyle to environment and genetics. Dr. Lim’s goal is to identify the underlying causes of health problems and develop customized treatment plans.
Using state-of-the-art diagnostics, genetic testing, and targeted therapies, he offers precision medicine precisely tailored to your individual genetic predisposition and clinical profile. His aim is not only to optimize treatment outcomes but also to sustainably improve your quality of life.
Dr. Lim focuses on continuous professional development and stays up-to-date with the latest developments in biological and precision medicine through training courses, conference participation and close collaboration with experts.
Board of Directors
Dr Lim Kah Meng
Group Managing Director / Executive DirectorScientist and experienced serial entrepreneur in the biotech & biopharma industry | Former A*Star researcher and professor in Nanyang Technology University of Singapore | Founder of GO-Dx Corporation | Board member of a Singapore listed biotech company
Lim Sah Soon
Executive DirectorChartered Surveyor and Chartered Secretary | Currently serving as Managing Director of charity organisation, Huaxia Cultural Hub Ltd | Also serves as a Director of two family companies, The Kindred Spirit Pte Ltd and Pheng Geck Pte Ltd | From 1978 to 1994, served as a Super-Scale Officer in Housing and Development Board, Prime-Minister Office, Ministry of Community Development and Singapore People Association | Appointed as Secretary General for the Singapore Chinese Chamber of Commerce & Industry (SCCCI) as well as the Honorary Secretary General of the then Singapore Federation of Chambers of Commerce & Industry from 1995 to 2013 | Since retirement from SCCCI in 2013, has served as a Member of the Practicing Management Consultants Certification Board in Singapore | Also chairs the Membership Affairs Committee of the Singapore Teochew Federation | Also serves as Council Member of TeoAnn Huey Kuan, Member of the TCM Board Disciplinary Investigation Panel, Advisor to World Lin Chamber of Commerce, and Advisor to Federation of World Cultural & Art Society | Conferred by the President of Singapore with PPA(P) & PPA(G), and was awarded the World Chinese Model
William Bass
Non-Executive DirectorAn Australian Director with considerable experience in corporate and listed companies | Has extensive commercial and financial knowledge from a range of leading Australian and international private and public companies. These include appointments as non-executive director and company secretary of ASX listed 1300SMILES Limited & China Magnesium Corporation Limited | Served as a director of Dementia Australia and Alzheimer’s Queensland | Active in a number of philanthropic and business innovation ventures | Served as Company Secretary to GE Capital Limited, Billabong International Limited, Country Road Limited and On Card International Limited | Fellow of the Institute of Chartered Secretaries, Governance Institute, and Institute for Independent Business, a Member of Australian Institute of Company Directors and an Associate of the Institute of Chartered Accountants Australia and New Zealand
Peh Chin Hua
Non-Executive DirectorChairman and CEO of White Group
| More than 50 years of experience in real estate, publishing and finance, with a focus on China | Led Dragon Land Limited (a real estate development company) as the Founder and Executive Chairman, from 1993 to 2004, listing it on the mainboard of Singapore Stock Exchange and completed eight large-scale projects in seven major cities in China | Served as Managing Director of the Shing Lee Group, a family publishing business, for more than two decades | Held several corporate positions as Vice Chairman of TFC Bank Holdings in the US and Chairman of Seacare Holdings in Singapore | Served as Member of Parliament in Singapore for 13 years and Vice Chairman of the Singapore Government’s Parliamentary Information, Arts and Education Committee | Currently an Advisor to the Singapore Association of Writers, the Chinese Calligraphy Society of Singapore, and the International Art and Culture (Singapore) Federation | Consultant to the Singapore Chinese Physicians’ Association and the Association for Promoting Chinese Medicine | Holds MBA from the National University of Singapore | Awarded Public Service Medal in 1984 by the President of Singapore
Justyn Stedwell
Non-Executive DirectorOver 15 years’ experience acting as an outsourced Company Secretary for ASX listed
companies within various industries | Assisted Lightning Minerals Ltd (ASX:L1M) through their successful IPO on the ASX in his capacity as Company Secretary | Currently the Company Secretary of Spenda Limited (ASX:SPX) | Previously Company Secretary of former ASX top 200 company Imugene Limited (ASX:IMU) for approximately 10 years | Has also served as a Non-Executive Director on several ASX listed company Boards | Completed a Bachelor of Commerce (Management & Economics) at Monash University, Graduate Diploma of Accounting at Deakin University and is a graduate of the Governance Institute of Australia | Sold his outsourced company secretary business with approximately 20 listed clients to Automic Group in 2021
Bill Pavlovski
Non-Executive DirectorExperienced Company Secretary and Non-Executive Director with over 15 years of governance, corporate advisory, and compliance experience across multiple international exchanges including the ASX, JSE, AIM, and NSX | Has an extensive background in corporate governance, risk management, capital markets, and regulatory compliance | His work spans listed and private entities, with particular strength in managing ASX Listing Rule requirements, IPO and capital raising processes, and board and shareholder communications | Currently serves as Non-Executive Director and Company Secretary of MC Mining Limited (ASX: MCM) and Company Secretary of OMG Group Limited (ASX: OMG)